- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03096548
Sun Safety Ink! A Sun Safety Program for the Tattoo Community
February 2, 2023 updated by: Klein Buendel, Inc.
Over 3.5 million cases of non-melanoma skin cancers occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system.
Klein Buendel, Inc. (KB) proposes to develop Sun Safety INK! (SSI!), a skin cancer prevention program targeted to clients of licensed tattoo studios because tattoo aftercare recommendations can include sun protection for tattoos, and studios offer an opportunity to reach younger adults who are significantly more likely to sunburn and less likely to practice sun safety.
The study will assess the effectiveness of SSI! at (1) increasing full-body comprehensive sun protection practices; (2) decreasing sun burning and tanning; and, (3) decreasing positive attitudes regarding tanning and tanning attractiveness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Skin cancer prevention is a public health priority.
Over 3.5 million cases of non-melanoma skin cancers (NMSC) occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system.
Increasing evidence points to the need for prevention programs to be targeted to young adults as invasive melanoma of the skin is the third most common cancer among adolescents and young adults (ages 15-39) in the U.S. Skin cancer is preventable as excess exposure to ultraviolet radiation (UVR), the primary risk factor, is modifiable and a number of public health campaigns have been developed to increase awareness about skin cancer risk and to promote sun safety.
Despite these efforts, skin cancer rates continue to rise.
Many adults still forget to apply sunscreen, do not pre-apply prior to sun exposure, fail to reapply, do not use clothing or wide-brimmed hats that physically block UVR and do not use shade.
4.2% of US adults engage in indoor tanning.
It is well established that continued efforts are needed to promote skin cancer prevention.
Concurrently, approximately, 25% of American adults have a tattoo with younger adults more likely to have tattoos than older adults.
The popularity of tattoos continues to grow in the general population and particularly among members of the military.
Individuals with tattoos need to take extra precaution when exposed to the sun not only to protect themselves from harmful UVR rays but also to reduce damage to their tattoos.
Klein Buendel, Inc. (KB) proposes to develop and test Sun Safety INK (SSI), a skin cancer prevention program targeted to clients of licensed tattoo studios.
The studios have been selected as the venue for this study because tattoo salons, at times, promote sun protection for new tattoos to keep them from fading, and offer a unique opportunity to reach younger adults who have high sunburn rates and are often less likely to practice sun protection.
The studios provide a unique and compatible environment for sun safety promotion.
Further, a number of successful programs have promoted health practices through similar venues such as beauty parlors and barber shops.
Exploratory research with the tattoo community determined that: (1) tattoo studios were receptive to a skin cancer prevention program; (2) tattooed individuals had high rates of sunburns and low rates of sun protection but were open to receiving sun safety information and (3) a prototype SSI! program confirmed feasibility for recruitment and implementation.
Based on these results, KB proposes to fully develop SSI! to include an online sun safety training for artists, a website, and additional sun safety education materials (e.g., social media).
KB will work with the Alliance of Professional Tattoo Artists and the National Tattoo Association to recruit 30 licensed studios to participate in a group-randomized pair-matched pretest-posttest controlled quasi-experimental design.
The primary outcomes of the study will be to evaluate the effectiveness of SSI! at: (1) increasing full-body comprehensive sun protection practices; (2) decreasing sun burning and tanning; and, (3) decreasing positive attitudes regarding tanning and tanning attractiveness.
Study Type
Interventional
Enrollment (Actual)
1820
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Denver
-
Golden, Colorado, United States, 80401
- Klein Buendel, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must be 18 years of age or older
- Must have received a tattoo in a licensed tattoo studio
Exclusion Criteria:
- Under 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Sun Safety Ink! Program
A program to (1) increase full-body sun comprehensive sun protection practices, (2) decrease sunburning and tanning and (3) decrease positive attitudes regarding tanning and tanning attractiveness of tattoo studio clients.
The program is comprised of a video based communication strategy training presented by research staff to artists of tattoo studios.
|
The intervention will be comprised of an online skin cancer prevention training for all tattoo artists of participating studios.
The training will include skin cancer rates and risk factors, tattoo rates, recommendations for sun protection practices, a rationale for the relationship of tattoo care and sun safety, and recommended communication strategies for artists to communicate skin cancer prevention to their clients.
Additional printed materials (tip-card for clients, posters) to be displayed in tattoo studios, a Sun Safety Ink! website, and social media messages for tattoo studios' Facebook and Pinterest pages will be provided.
|
|
ACTIVE_COMPARATOR: Attention Control
The attention control group will provide standard tattoo aftercare instructions to their clients.
|
Studios and artists in this attention control group will not receive the Sun Safety Ink! program.
They will continue to provide standard aftercare instructions to clients.
The program will be provided to them at the end of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sun Protection by Client (online survey)
Time Frame: Baseline, 1 Month Posttest, 6 Month Posttest
|
Sun protection practices (sunscreen application/reapplication and Sun Protection Factor (SPF); use of lip balm, hats, protective clothing, sunglasses, shade) of tattooed and non-tattooed skin will be assessed in an online survey.
|
Baseline, 1 Month Posttest, 6 Month Posttest
|
|
Change in Number of Sunburns
Time Frame: Baseline, 1 Month Posttest, 6 Month Posttest
|
Participants will report number of sunburns in the past 12 months.
|
Baseline, 1 Month Posttest, 6 Month Posttest
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Tanning Behaviors (online survey)
Time Frame: Baseline, 1 Month Posttest, 6 Month Posttest
|
Participants will complete an online survey that focuses on tanning frequency for both indoor and outdoor tanning.
|
Baseline, 1 Month Posttest, 6 Month Posttest
|
|
Change in Tanning Attitudes (online survey)
Time Frame: Baseline, 1 Month Posttest, 6 Month Posttest
|
Participants will complete an online survey that focuses on a six-item tanning image scale (1= strongly agree to 5= strongly disagree).
|
Baseline, 1 Month Posttest, 6 Month Posttest
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Barbara Walkosz, PhD, Klein Buendel, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 15, 2017
Primary Completion (ACTUAL)
December 31, 2022
Study Completion (ACTUAL)
December 31, 2022
Study Registration Dates
First Submitted
March 14, 2017
First Submitted That Met QC Criteria
March 24, 2017
First Posted (ACTUAL)
March 30, 2017
Study Record Updates
Last Update Posted (ACTUAL)
February 6, 2023
Last Update Submitted That Met QC Criteria
February 2, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0315
- R01CA206569 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Cancer
-
Abramson Cancer Center at Penn MedicineRecruitingSkin Cancer Face | Skin Cancer ScalpUnited States
-
University of HawaiiVA Palo Alto Health Care SystemCompletedCancer, Other Than Non-melanoma Skin CancerUnited States
-
EnlundCompletedBreast Cancer | Skin Cancer | Colo-rectal CancerSweden
-
Xoft, Inc.Eminence Clinical Research, Inc.CompletedNonmelanoma Skin CancerUnited States
-
SciBase ABRecruitingKeratinocyte Skin CancerGermany
-
Rutgers, The State University of New JerseyCompleted
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedSkin Cancer PreventionUnited States
-
McMaster UniversityRecruitingSkin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient SatisfactionCanada
-
National University Hospital, SingaporeNot yet recruitingSkin Cancer | Skin Cancer Prevention | Benign Skin Growth
-
University of Alabama at BirminghamNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
Clinical Trials on Sun Safety Ink! Program
-
Rutgers, The State University of New JerseyCompleted
-
Universidade do PortoUniversity of Coimbra; Aveiro University; Foundation for Science and Technology... and other collaboratorsActive, not recruiting
-
Northwestern UniversityCompletedSkin Cancer | Sun Sensitivity | Sun ProtectionUnited States
-
Centre Hospitalier Universitaire de la RéunionCompleted
-
Klein Buendel, Inc.National Cancer Institute (NCI); University of Colorado, Denver; Kaiser Foundation...CompletedSkin CancerUnited States
-
Klein Buendel, Inc.University of Colorado, Denver; Kaiser Foundation Research InstituteCompletedSkin CancerUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedUrinary Tract Infection | Pressure Ulcer | Accidental FallsNetherlands
-
University of ConnecticutNational Cancer Institute (NCI)Completed
-
University of Nebraska LincolnNational Institutes of Health (NIH)Completed
-
Istanbul Medipol University HospitalCompletedPatient Outcomes | Simulation Based LearningTurkey